Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diabetes self-management is universally regarded as a foundation of diabetes care. We determined whether comparable glycemic control could be achieved by self-titration versus physician titration of a once-daily bolus insulin dose in patients with type 2 diabetes who are unable to achieve optimal glycemia control with a basal insulin. RESEARCH DESIGN AND METHODS: Patients with type 2 diabetes, an HbA1c level >7% (53 mmol/mol), and either nocturnal hypoglycemia episodes or an insufficient basal insulin glargine level (with or without oral agents) to achieve a fasting plasma glucose level ≤6 mmol/L (108 mg/dL) were studied. Participants all had bolus insulin glulisine added at breakfast and were allocated to either algorithm-guided patient self-titration or physician titration. The primary outcome was an HbA1c level ≤7% (53 mmol/mol) without severe hypoglycemia. RESULTS: After a mean (SD) follow-up of 159.4 days (36.2 days), 28.4% of participants in the self-titration arm vs. 21.2% in the physician titration arm achieved an HbA1c level of ≤7% (53 mmol/mol) without severe hypoglycemia (between-group absolute difference 7.2%; 95% CI −3.2 to 17.7). The lower end of this 95% confidence interval was within the predetermined noninferiority boundary of −5% (P noninferiority = 0.011). CONCLUSIONS: In stable patients with type 2 diabetes who are receiving doses of basal insulin glargine who require bolus insulin, a simple bolus insulin patient-managed titration algorithm is as effective as a physician-managed algorithm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the contrary, a study on the difference in insulin intensification between patient self-management versus physicians’ management revealed a higher mean weight for the patients managed group [26].”
In the citing paper
“Strengthening the importance of independence in the treatment of diabetes, one study emphasized that patient-managed dosage titration for simple bolus insulin is as effective as physician-driven dosage adjustment [26].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461
Patient empowerment: myths and misconceptions
Anderson, R. M., & Funnell, M. M. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2009.07.025 · Cited by 846 · cited 1×
“The START study used an empowerment approach (31) to patient care by supporting patients to make autonomous, informed decisions about their diabetes self-management.”
MethodThree-year efficacy of complex insulin regimens in type 2 diabetes
Holman, R. R., Farmer, A. J., Davies, M. J., Levy, J. C., Darbyshire, J. L., Keenan, J. F., & Paul, S. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905479 · Cited by 667
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434
Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes
Woerle, H. J., Neumann, C., Zschau, S., Tenner, S., Irsigler, A., Schirra, J., Gerich, J. E., & Göke, B. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.11.011 · Cited by 316
Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes
Davies, M., Storms, F., Shutler, S., Bianchi-Biscay, M., Gomis, R., & for the AT.LANTUS Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1282 · Cited by 314
Riddle, M., Umpierrez, G., DiGenio, A., Zhou, R., & Rosenstock, J. (2011) · Diabetes Care · doi:10.2337/dc11-0632 · Cited by 219
Patient empowerment and optimal glycemic control
White, R. D. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.677417 · Cited by 41
Research works printed but not linked: 24
- Wright, 2002, Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57), Diabetes Care, 25, 330, 10.2337/diacare.25.2.330 · DOI · Paper page
- Jaakkimainen, 2003, Sources of physician care for people with diabetes, 181
- Harris, 2010, Clinical inertia in patients with T2DM requiring insulin in family practice, Can Fam Physician, 56, e418
- Yki-Järvinen, 2004, Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue, Eur J Clin Invest, 34, 410, 10.1111/j.1365-2362.2004.01356.x · DOI
- Chapman, 2002, Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus, Drugs, 62, 1945, 10.2165/00003495-200262130-00014 · DOI
- Gerstein, 2006, A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study, Diabet Med, 23, 736, 10.1111/j.1464-5491.2006.01881.x · DOI · Paper page
- Harris, 2008, Can family physicians help patients initiate basal insulin therapy successfully? Randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial, Can Fam Physician, 54, 550
- Meece, 2006, Dispelling myths and removing barriers about insulin in type 2 diabetes, Diabetes Educ, 32, 9S, 10.1177/0145721705285638 · DOI · Paper page
- Monnier, 2007, The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes, Diabetes Care, 30, 263, 10.2337/dc06-1612 · DOI · Paper page
- Monnier, 2011, Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts, Diabetes Technol Ther, 13, S25, 10.1089/dia.2010.0239 · DOI · Paper page
- Peter, 2009, Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with type 2 diabetes, Diabet Med, 26, 974, 10.1111/j.1464-5491.2009.02809.x · DOI
- Ceriello, 2010, The glucose triad and its role in comprehensive glycaemic control: current status, future management, Int J Clin Pract, 64, 1705, 10.1111/j.1742-1241.2010.02517.x · DOI
- Pearson, 2006, Systematically initiating insulin: the staged diabetes management approach, Diabetes Educ, 32, 19S, 10.1177/0145721705285640 · DOI
- Inzucchi, 2012, Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetes Care, 35, 1364, 10.2337/dc12-0413 · DOI · Paper page
- Davidson, 2011, A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure, Endocr Pract, 17, 395, 10.4158/EP10323.OR · DOI
- Lankisch, 2008, Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs, Diabetes Obes Metab, 10, 1178, 10.1111/j.1463-1326.2008.00967.x · DOI · Paper page
- Raccah, 2007, When basal insulin therapy in type 2 diabetes mellitus is not enough—what next?, Diabetes Metab Res Rev, 23, 257, 10.1002/dmrr.733 · DOI · Paper page
- Bradley, 2007, The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ, Health Qual Life Outcomes, 5, 57, 10.1186/1477-7525-5-57 · DOI · Paper page
- Selam, 2009, Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial, 194
- Peyrot, 2005, Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study, Diabetes Care, 28, 2673, 10.2337/diacare.28.11.2673 · DOI · Paper page
- Davis, 2006, Psychological insulin resistance: overcoming barriers to starting insulin therapy, 146S
- Kunt, 2009, Barriers to insulin initiation and intensification and how to overcome them, 6
- Peyrot, 2004, Psychological insulin resistance: overcoming barriers to insulin therapy, Practical Diabetology, 23, 6
- Funnell, 2004, Empowerment and self-management of diabetes, 123
Cited by
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Hoekstra, T., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., & van Raalte, D. H. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12985 · Cited by 62
“After 8 weeks, median (IQR) iGlu dose was 17 (8-29) units/d.”
BackgroundSharma, S. K., Thakur, K., Kant, R., & Mudgal, S. K. (2021) · Cureus · doi:10.7759/cureus.20436 · Cited by 13
Metadata
- Authors
- Harris, S. B., Yale, J.-F., Berard, L., Stewart, J., Abbaszadeh, B., Webster-Bogaert, S., & Gerstein, H. C.
- Affiliations
- Department of Family Medicine, The University of Western Ontario, London, Ontario, Canada
- Department of Medicine, McGill University, Montreal, Quebec, Canada
- Winnipeg Regional Health Authority, Health Sciences Centre, Winnipeg Diabetes Research Group, Winnipeg, Manitoba, Canada
- Sanofi Canada, Medical and Regulatory Affairs, Montreal, Quebec, Canada
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-02-11
- Volume
- 37
- Issue
- 3
- Pages
- 604-610
- ISSN
- 0149-5992
- 1935-5548
- Cited by
- 19
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study. https://app.cochat.ai/papers/10.2337/dc13-1636
- The paper
- Harris, S. B., Yale, J.-F., Berard, L., Stewart, J., Abbaszadeh, B., Webster-Bogaert, S., & Gerstein, H. C. (2014). Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study. Diabetes Care. https://doi.org/10.2337/dc13-1636
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.